Alnylam Pharmaceuticals reported third-quarter 2025 earnings, achieving US$1.25 billion in revenue and a net income of US$251.08 million, while also raising full-year revenue guidance to between US$2.
On October 23, 2025, Ananym Capital Management LP urged LKQ Corporation to divest its European operations and auto specialties division, collaborating with investment banks to review portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback